Synchron's Breakthrough Brain-Computer Interface Helping Treat Paralysis

Australian company Synchron has developed a brain chip called the Stentrode that helps people with paralysis communicate by controlling digital devices with their thoughts.  The groundbreaking medical device is implanted into the motor cortex without open brain surgery. It has been trialed successfully with several Australian patients and is the first device to be approved by the FDA for a US clinical trial starting later this year. The project is making headlines around the world and is funded through MTPConnect’s BioMedTech Horizons program, an MRFF initiative. We catch up with the founders - Associate Professor Thomas Oxley, Synchron’s Chief Executive Officer, Vascular and Interventional Neurologist at Mount Sinai Hospital in New York City, and co-head of the Vascular Bionics Laboratory at the University of Melbourne, Australia and Associate Professor Nicholas Opie, Synchron’s Chief Technology Officer and co-head of the Vascular Bionics Laboratory at the University of Melbourne, Australia. www.synchron.com